MedAssurant Announces Breakthrough in Healthcare Data Analytical Power

BOWIE, Md., Jan. 25, 2011 /PRNewswire/ -- MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced the achievement of a ground-breaking milestone in healthcare data analytics with the full implementation of its Quality Spectrum Cluster Logic (QSCL™) technology, a proprietary analytical data structure designed to enable acceleration of complex healthcare data analyses. This powerful innovation has been shown to increase healthcare data analytical process runs by a factor of 2,000 over methodologies previously available.

The culmination of more than four years of research and development, QSCL offers straightforward measure design and unrivaled querying performance.  In parallel with the development of QSCL, MedAssurant has optimized the current analytical toolsets that drive the company's system processes and insight into healthcare data.

Additionally, MedAssurant has integrated its Medical Outcomes Research for Effectiveness & Economics Registry (MORE2 Registry™) dataset into the QSCL platform.  The MORE2 Registry is an industry-leading healthcare data asset comprised of more than 3.9 billion medical events from more than 76 million patients, 295,000 physicians and 185,000 clinical facilities throughout the United States. Through the power of these combined capabilities, MedAssurant can run highly sophisticated clinical analytics across billions of events within minutes – a process that would have previously required several weeks to complete.

"This is a significant advancement in healthcare data analytical power above any system or platform available in today's marketplace," commented Greg Jones, chief technology officer at MedAssurant. "The unique design, enabled through a proprietary, hardware-agnostic MPP (Massively Parallel Processing) engine, allows for the use of unique data structures combined with optimized processing algorithms to yield industry-leading performance. In addition to expanding the company's client solution arsenal, QSCL is a clear demonstration of how MedAssurant is advancing the core technologies available to empower a more advanced generation of technology-enabled solutions in healthcare."

Cary Sennett, M.D., Ph.D., MedAssurant's chief medical officer and head of the company's Clinical & Statistical research team, added, "In a landscape where comparative effectiveness research (CER), outcomes analyses, pharmacovigilence and other forms of healthcare insight have become increasingly critical, our ability to run complex algorithms at such speeds, across large datasets will further advance MedAssurant's capabilities."

Beyond accelerating analytics applied to client needs, the improved performance will further empower MedAssurant's product design, development and operational capabilities.

"Our industry-leading datasets provide us with a significant advantage in bringing value to our clients," said Dan Rizzo, CFA, MedAssurant's chief product officer. "As part of our design-build-operate strategy, MedAssurant leverages datasets through applications of population simulations, matched peer cohort analyses, intervention effectiveness design, relative comparative metrics development, and a host of processes which provide us with a more rapid path for product design and enhancement. The achievement of QSCL will dramatically accelerate this – unlocking new opportunities and yielding our clients even greater value going forward."

The availability of QSCL within MedAssurant's solution arsenal will immediately begin driving functional improvements within the company's Clinical & Quality Outcomes, Healthcare Data Insights, and Business Intelligence solutions.  Full functionality enhancements will become effective within the next three months as the company's product enhancement cycle completes.

About MedAssurant, Inc.

MedAssurant, Inc., is a leading technology-enabled healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvement in clinical and quality outcomes, care management and financial performance throughout the healthcare community. Proprietary healthcare datasets, aggregation and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess and deep human resources, empowers MedAssurant's advanced generation of healthcare assessment and improvement through highly informed solutions. Driven by a mission to improve today's healthcare landscape, the employees of MedAssurant proudly apply care, ingenuity and dedication to delivering a new approach to healthcare touching more than 100 million Americans – one driven by data and insight – one resulting in meaningful action. Please visit www.medassurant.com for more information.

SOURCE MedAssurant, Inc.